Skip to main content

Table 2 Input variables used in estimating health care costs

From: Government use licenses in Thailand: an assessment of the health and economic impacts

Parameters

USD/yr

References

EFV-based ARVs treatment

1,922

[44]

NVP-based ARVs treatment

3,087

[44]

LPV/r-based ARVs treatment

910

DMSIC

IDV/r-based ARVs treatment

1,210

DMSIC

clopidogrel plus aspirin for secondary prevention of ischemic heart disease

19

DMSIC

aspirin alone for secondary prevention of ischemic heart disease

2

DMSIC

letrozole for treatment of breast cancer

78

DMSIC

tamoxifen for treatment of breast cancer

111

DMSIC

docetaxel for treatment of breast cancer

225

DMSIC

paclitaxel for treatment of breast cancer

1,826

DMSIC

docetaxel for treatment of lung cancer

188

DMSIC

pemetrexed for treatment of lung cancer

5,470

DMSIC

erlotinib for treatment of lung cancer

2,684

DMSIC